Arterial stiffness and endothelial function in patients with β-thalassemia major

Circulation

Volumn 106, Issue 20, 2002, Pages 2561-2566

  Cheung, Y F ^a   Chan, Godfrey C F ^a   Ha, S Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Arteries; Endothelium; Ventricles

Indexed keywords

FERRITIN; GLYCERYL TRINITRATE;

ADULT; ARTERY MALFORMATION; ARTICLE; BLOOD VESSEL TONE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIUM INJURY; FEMALE; FERRITIN BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPEREMIA; MALE; PRIORITY JOURNAL; THALASSEMIA MAJOR; VASODILATATION;

ADULT; ARTERIES; BETA-THALASSEMIA; BRACHIAL ARTERY; CAROTID ARTERIES; COMPLIANCE; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; FERRITINS; HUMANS; MALE; VASODILATION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0037069422     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000037225.92759.A7     Document Type: Article

References (38)

1. Lewis SB, Rachmilewitz AE, Amitai N, et al. Left ventricular function in β-thalassemia and the effect of multiple transfusion. Am Heart J. 1978;96:636-645.
2. Kremastinos DT, Tsiapras DP, Tsetos GA, et al. Left ventricular diastolic Doppler characteristics in β-thalassemia major. Circulation. 1993;88:1127-1135.
3. Livera MA, Tesoriere L, Maggio A, et al. Oxidative modification of low-density lipoprotein and atherogenic risk in β-thalassemia. Blood. 1998;10:3936-3942.
4. Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86:803-811.
5. Roest M, van der Schouw YT, de Valk B, et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation. 1999;100:1268-1263.
6. Cortia MC, Gaziano M, Hennekens CH. Iron status and risk of cardiovascular disease. Ann Epidemiol. 1997;7:62-68.
7. Gillum RF. Body iron stores and atherosclerosis. Circulation. 1997;96:3261-3263.
8. Duffy SJ, Biegelsen ES, Holbrook M, et al. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 2001;103:2799-2804.
9. Banjerdpongchai R, Wilairat P, Fucharoen S, et al. Morphological alterations and apoptosis of endothelial cells induced by thalassemic serum in vitro. Southeast Asian J Trop Med Public Health. 1997;28(suppl 3):149-154.
10. Butthep P, Khuhapinant A, Bunyaratvej A, et al. Thalassemic serum inhibits endothelial cell mitosis in vitro. Southeast Asian J Trop Med Public Health. 1997;28(suppl 3):155-160.
11. Ramsey MW, Goodfellow J, Jones CJH, et al. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation. 1995;92:3212-3219.
12. Joannides R, Richard V, Haefeli WE, et al. Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans. Hypertension. 1997;30:1465-1470.
13. Tsomi K, Karagiorga-Lagana M, Fragodimitri C, et al. Arterial elastorrhexis: Manifestation of a generalized elastic tissue disorder in β-thalassemia major. Eur J Haematol. 1999;63:287-294.
14. Aessopos A, Samarkos M, Voskaridou E, et al. Arterial calcification in β-thalassemia. Angiology. 1998;49:137-143.
15. Nichols WW, O'Rourke MF. Vascular impedance. In: McDonalds's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 4th Ed. London, UK: Edward Arnold; 1998:54-97,243-293.
16. Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111-1117.
17. Devereux RB, Lutas EM, Casale PN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984;4:1222-1230.
18. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
19. Hirai T, Sasayama S, Kawasaki T, et al. Stiffness of systemic arteries in patients with myocardial infarction: A noninvasive method to predict severity of coronary atherosclerosis. Circulation. 1989;80:78-86.
20. Greenwald SE, Denyer HT, Sobeh MS. Non invasive measurement of vascular compliance by a photoplethysmographic technique. SPIE Proc. 1997;2970:89-97.
21. Cheung YF, Taylor MJO, Fisk NM, et al. Fetal origins of reduced arterial distensibility in the donor twin in twin-twin transfusion syndrome. Lancet. 2000;355:1157-1158.
22. Celermajer DS, Sorensen KE, Gooch VE, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
23. Butthep P, Bunyaratvej A, Funahara Y, et al. Possible evidence of endothelial cell activation and disturbance in thalassemia: An in vitro study. Southeast Asian J Trop Med Public Health. 1997;28(suppl 3):141A-148A.
24. Kyriakou DS, Alexandrakis MG, Kyriakou ES, et al. Activated peripheral blood and endothelial cells in thalassemia patients. Ann Hematol. 2001;80:577-583.
25. Rodriguez-Crespo I, Nishida CR, Knudsen GM, et al. Mutation of the five conserved histidines in the endothelial nitric-oxide synthase hemoprotein domain. J Biol Chem. 1999;274:21617-21624.
26. Smith C, Mitchinson MJ, Aruoma OI, et al. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J. 1992;286:901-905.
27. Cardoso LE, Mourao PA. Compositional and structural alterations of arterial glycosaminoglycans associated with the complications brought about by thalassemia major: A case report. Angiology. 1996;47:175-183.
28. Gardiner HM, Celermajer DS, Sorensen KE, et al. Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood. Circulation. 1994;89:1745-1750.
29. Bank AJ, Wilson RF, Kubo SH, et al. Direct effects of smooth muscle relaxation and contraction on in vivo human brachial artery elastic properties. Circ Res. 1995;77:1008-1016.
30. Maiolo M, Vigna GB, Tonolo G, et al. Plasma lipoprotein composition. Apolipoprotein (a) concentration and isoforms in β-thalassemia. Atherosclerosis. 1997;131:127-133.
31. Jessup M, Manno CS. Diagnosis and management iron-induced heart disease in Cooley's anemia. Ann N Y Acad Sci. 1998;850:242-250.
32. Kremastinos DT, Tiniakos G, Theodorakis GN, et al. Myocarditis in β-thalassemia major: A cause of heart failure. Circulation. 1995;91:66-71.
33. Kremastinos DT, Flevari P, Spyropoulou M, et al. Association of heart failure in homozygous β-thalassemia with the major histocompatibility complex. Circulation. 1999;100:2074-2078.
34. Nielsen P, Fischer R, Engelhardt R, et al. Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol. 1995;91:827-833.
35. Li CK, Chik KW, Lam CWK, et al. Liver disease in transfusion dependent thalassaemia major. Arch Dis Child. 2002;86:344-347.
36. Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000;343:327-331.
37. Whitmore RL. Rheology of the Circulation. Oxford, UK: Pergamon Press; 1968.
38. Hoeks AP, Samijo SK, Brands PJ, et al. Noninvasive determination of shear-rate distribution across the arterial lumen. Hypertension. 1995;26:26-33.